Skip to main content
. 2022 Jan 25;11(3):231–236. doi: 10.4103/EUS-D-21-00096

Table 5.

Indications and outcomes of lumen apposing metal stent placement

Type of study Number of patients Indication for LAMS Technical success (%) Clinical success (%) Adverse events (%) Reference
Meta-analysis 737 Pancreatic walled off necrosis - 88.5% (95% CI 82.5-92.6 11.2% (95% CI 6.8-17.9) Mohan et al.
Meta-analysis 332 Pancreatic pseudocysts 95.76% 94.06% - Lyu et al.
Meta-analysis 1437 Biliary drainage 91.5% (95% CI 87.7-94.2) 87% (95% CI 82.3-90.6) 17.9% (95% CI 14.3-22.2) Dhindsa et al.
Meta-analysis 278 Palliation of gastric outlet obstruction 95.2% (CI 87.2-98.3) 93.3% (CI 84.4-97.3) 10.7% (CI 4.3-24.5) Chandan et al.
Meta-analysis 1538 Symptomatic gallbladder disease 94.65% (95% CI 91.54-96.67) 92.06% (95% CI 88.65-94.51) 11.71% (95% CI 8.92-15.23) McCarty et al.
Retrospective 46 Malignant distal biliary obstruction 93.5% 97.7% 11.6% Anderloni et al.
Multicenter retrospective 47 Postsurgical fluid collections 93.6% 89.3% 4.25% Mudireddy et al.

CI: Confidence interval; LAMS: Lumen-apposing stent